EBITDA for Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current EBITDA (TTM) is -$1.34B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
-$1.34B
YoY change
+60.9%
5Y CAGR
N/A
Peak year (2017)
-$29.84M
Cumulative EBITDA
-$2.89B
EBITDA history chart for Revolution Medicines (RVMD) from 2017 to 2025
EBITDA history table for Revolution Medicines (RVMD) from 2017 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | -$1.09B | +60.9% | -$412.81M | ||
| 2024 | -$677.70M | +41.8% | -$199.82M | ||
| 2023 | -$477.88M | +92.2% | -$229.25M | ||
| 2022 | -$248.62M | +38.3% | -$68.88M | ||
| 2021 | -$179.75M | +76.4% | -$77.83M | ||
| 2020 | -$101.91M | +109.7% | -$53.33M | ||
| 2019 | -$48.59M | +21.7% | -$8.68M | ||
| 2018 | -$39.91M | +33.8% | -$10.07M | ||
| 2017 | -$29.84M | — | — |
EBITDA values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Revolution Medicines (RVMD) most recent annual EBITDA stands at -$1.09B (2025) – surged 60.9% year-over-year.
2017 marks the peak EBITDA at -$29.84M, with the historical low of -$1.09B recorded in 2025.
Within Healthcare, Revolution Medicines (RVMD) ranks 9th among 8 peers we track. The peer median for EBITDA is $25.50B.
Revolution Medicines EBITDA by Year
Revolution Medicines EBITDA 2025: -$1.09B
Revolution Medicines EBITDA in 2025 was -$1.09B, surged 60.9% from 2024. This figure represents the lowest annual value in the available history.
Revolution Medicines EBITDA 2024: -$677.70M
Revolution Medicines EBITDA in 2024 was -$677.70M, surged 41.8% from 2023.
Revolution Medicines EBITDA 2023: -$477.88M
Revolution Medicines EBITDA in 2023 was -$477.88M, surged 92.2% from 2022.
Revolution Medicines EBITDA 2022: -$248.62M
Revolution Medicines EBITDA in 2022 was -$248.62M, surged 38.3% from 2021.
Revolution Medicines EBITDA 2021: -$179.75M
Revolution Medicines EBITDA in 2021 was -$179.75M.
See more financial history for Revolution Medicines (RVMD).
Sector peers — EBITDA
Companies in the same sector as Revolution Medicines, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Merck & Co. (MRK) | $29.32B | Healthcare |
| Eli Lilly (LLY) | $27.94B | Healthcare |
| UnitedHealth Group (UNH) | $23.06B | Healthcare |
| AstraZeneca (AZN) | $19.83B | Healthcare |
| AbbVie (ABBV) | $17.63B | Healthcare |
| Amgen (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Revolution Medicines's EBITDA?
Latest reported EBITDA for Revolution Medicines (RVMD) is -$1.34B (period ending March 31, 2026).
How has Revolution Medicines EBITDA changed year-over-year?
Revolution Medicines (RVMD) EBITDA changed +60.9% year-over-year on the latest annual filing.
When did Revolution Medicines EBITDA hit its highest annual value?
Revolution Medicines EBITDA reached its highest annual value of -$29.84M in 2017.
What was Revolution Medicines EBITDA in 2024?
Revolution Medicines (RVMD) EBITDA in 2024 was -$677.70M.
What was Revolution Medicines EBITDA in 2025?
Revolution Medicines (RVMD) EBITDA in 2025 was -$1.09B.
RVMD Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RVMD Overview
Company profile, financial tools, and key metrics
RVMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RVMD How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
RVMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RVMD Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
RVMD Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.